PTNTD — Palatin Technologies Share Price
Last trade - 00:00- $5.38m
- $2.86m
- $4.49m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 2.95 | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | n/a | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 15.37 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | n/a | ||
| Return on Equity | n/a | ||
| Operating Margin | -6723.22% | ||
Financial Summary
| Year End 30th Jun | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 0.12 | -0.19 | 1.47 | 4.85 | 4.49 | n/a | 74.48 | -40.52% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Palatin Technologies, Inc. is a biopharmaceutical company. The Company is developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor systems, with targeted, receptor-specific product candidates for the treatment of diseases with significant unmet medical need and commercial potential. The melanocortin receptor (MCr) system has effects on food intake, metabolism, sexual function, inflammation, and immune system responses. There are five melanocortin receptors, MC1r through MC5r. The Company's product development activities are focused on obesity, including co-administration of bremelanotide with tirzepatide, a GLP-1 agonist for treatment of obesity; ocular indications, including PL9643, an ophthalmic peptide solution for dry eye disease (DED), and ulcerative colitis, including PL8177, an oral peptide formulation. Its pipeline also includes PL7737 and PL9588. The Company's PL9588 is being developed as a topical treatment for glaucoma.
Directors
- John Prendergast NEC (67)
- Carl Spana PRE (59)
- Stephen Wills CFO (64)
- Robert deVeer IND (75)
- Alan Dunton IND (67)
- Joseph Hull IND (69)
- Anthony Manning IND (59)
- Arlene Morris IND (69)
- Last Annual
- June 30th, 2024
- Last Interim
- March 31st, 2025
- Incorporated
- November 21st, 1986
- Public Since
- December 21st, 1999
- No. of Shareholders
- 90
- No. of Employees
- 30
- Sector
- Biotechnology & Medical Research
- Industry
- Healthcare
- Exchange
- Pink Sheets on Nasdaq
- Shares in Issue
- 969,356
- Address
- 4-B Cedar Brook Drive, CRANBURY, 08512
- Web
- https://www.palatin.com/
- Phone
- +1 6094952200
- Auditors
- KPMG LLP
Similar to PTNTD
Actavia Life Sciences
Pink Sheets on Nasdaq
Acura Pharmaceuticals
Pink Sheets on Nasdaq
Adhera Therapeutics
Pink Sheets on Nasdaq
Ramoil Management
Pink Sheets on Nasdaq
Adynxx
Pink Sheets on Nasdaq
FAQ
As of Today at 22:32 UTC, shares in Palatin Technologies are trading at $5.55. This share price information is delayed by 15 minutes.
Shares in Palatin Technologies last closed at $5.55 and the price had moved by -91.9% over the past 365 days. In terms of relative price strength the Palatin Technologies share price has underperformed the S&P500 Index by -93.02% over the past year.
The overall consensus recommendation for Palatin Technologies is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out morePalatin Technologies does not currently pay a dividend.
Palatin Technologies does not currently pay a dividend.
Palatin Technologies does not currently pay a dividend.
To buy shares in Palatin Technologies you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $5.55, shares in Palatin Technologies had a market capitalisation of $5.38m.
Here are the trading details for Palatin Technologies:
- Country of listing: United States
- Exchange: PNK
- Ticker Symbol: PTNTD
Based on an overall assessment of its quality, value and momentum Palatin Technologies is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Palatin Technologies is $7.00. That is 26.13% above the last closing price of $5.55.
Analysts covering Palatin Technologies currently have a consensus Earnings Per Share (EPS) forecast of -$0.99 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Palatin Technologies. Over the past six months, its share price has underperformed the S&P500 Index by -89.68%.
As of the last closing price of $5.55, shares in Palatin Technologies were trading -81.53% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Palatin Technologies PE ratio based on its reported earnings over the past 12 months is 2.95. The shares last closed at $5.55.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Palatin Technologies' management team is headed by:
- John Prendergast - NEC
- Carl Spana - PRE
- Stephen Wills - CFO
- Robert deVeer - IND
- Alan Dunton - IND
- Joseph Hull - IND
- Anthony Manning - IND
- Arlene Morris - IND